Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2005

Mar 28, 2005

30339_dirs_2005-03-28_3fe53915-f9de-40cd-9c9f-403e3b9c225d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-03-24

Reporting Person: KEATING ROBERT J (Pres. Europe & Asia Pacific, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-03-24 Common stocks M 881 $13.0157 Acquired 25762.5326 Direct
2005-03-24 Common stocks S 881 $23.7709 Disposed 24881.5326 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2005-03-24 Stock Option (Right to buy) $13.0157 M 881 Disposed 2005-03-25 Common Stock (881.00) Direct

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.